24 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
of a label update for LUPKYNIS which now includes long-term efficacy data from our AURORA Clinical Program. We have also launched an innovative new marketing
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
18 Apr 22
Additional proxy soliciting materials
7:36am
, we bolstered our pipeline with two new innovative programs. We announced the acquisition of two novel, preclinical compounds: AUR200 and AUR300
8-K
EX-99.1
z066 cxkm929d
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
8-K
EX-99.1
beggq 078pkz
17 Jun 21
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
4:36pm
10-K
pgotwf47
24 Feb 21
Annual report
4:09pm
8-K
EX-99.1
5joempvqxlp188o1s1
25 Jan 21
Financial Statements and Exhibits
8:21am
6-K
EX-99.1
egn7f qnk
21 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
4:05pm
6-K
EX-99.1
1okgu4 pg1t3kkbddj8p
16 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
eyc4onclni978kb40bny
11 Aug 20
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
EX-99.1
nykr9rys
20 Apr 20
Aurinia Pharmaceuticals Inc. 6-K
9:00am
6-K
EX-99.1
9wo1j3s k1m293
25 Feb 20
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.1
r9kgns tj68
6 Dec 19
Aurinia Pharmaceuticals Inc. 6-K
11:40am
6-K
EX-99.1
pm3t2g7ywy0lgajkq5do
14 Mar 19
Aurinia Recognizes World Kidney Day and National Kidney Month with New Activities Focused on Raising Awareness for Kidney Disease
7:00am
6-K
EX-99.1
qthg3hzwn1ex3x
26 Jun 14
Aurinia to Present at the BIO International Convention
12:00am
40FR12B/A
EX-99.15
sbjtk
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am